Aging’s Shocking Two-Stage Process

A younger persons hand gently holding an elderly persons hand on a quilted surface

A landmark theory published in late 2025 suggests that the cancer or arthritis you develop at 65 may have been quietly set in motion by an infection, injury, or genetic mutation you experienced decades earlier.

Story Snapshot

University College London researchers propose a two-stage aging model where early-life biological damage lies dormant, then gets unleashed by age-related genetic changes later in life.
The model names osteoarthritis, cancer, and late-life infection recurrence as diseases that follow this pattern of early disruption followed by later-life biological unmasking.
The theory is a peer-reviewed synthesis, not yet a validated longitudinal study, meaning it is a compelling framework still awaiting direct experimental proof.
A separate Stanford Medicine study found that the human body undergoes massive molecular shifts in the mid-40s and early 60s, lending independent weight to the idea that aging is not a smooth, gradual process.

The Seed-and-Soil Idea That Changes How We Think About Getting Old

Researchers David Gems, Carver, and Zhao at University College London published a review in December 2025 in the journal Aging-US proposing what they call a two-stage model for the development of diseases of aging. ^[4] The first stage involves early-life disruptions, including infection, mechanical injury, and genetic mutation, that damage normal biological function but remain contained. The second stage begins when later-life genetic activity unmasks those dormant injuries, driving progression to major pathology and, ultimately, death. ^[4] The authors describe these latent injury sites as seeds that germinate in old age.

That seed-and-soil analogy is more than poetic. It reframes the central question of aging medicine from why do old people get sick to when did the damage actually begin. The review specifically identifies osteoarthritis, cancer, and late-life recrudescence of infection as pathologies consistent with this framework. ^[4] If the model holds up, it means clinicians treating a 70-year-old’s joint destruction or tumor may be managing a process that started in the patient’s 20s or 30s, long before any symptom appeared.

Why the Body’s Own Genes Become the Trigger

The mechanism the authors describe is not simply wear and tear. They argue that wild-type gene action, meaning normal genetic programming that governs later-life biological changes, actively unmasks earlier latent damage rather than just failing to suppress it. ^[4] This is a meaningful distinction. It suggests aging is not purely passive deterioration but includes programmatic biological activity that, however well-intentioned evolutionarily, ends up exposing old wounds. A separate Frontiers review supports this framing by describing aging as a two-phase process in which an initial linear risk phase gives way to an abrupt expression of aging hallmarks including chronic inflammation, stem cell exhaustion, and altered cellular communication. ^[5]

The Stanford Medicine finding adds a striking empirical layer. A study tracking more than 135,000 molecules and microbes in people aged 25 to 75 found that most biological markers do not shift gradually. Instead, they cluster into two bursts of rapid change, one around the mid-40s and one in the early 60s. ^[10] That non-linear pattern does not prove the two-stage disease model, but it independently confirms that aging biology operates in phases rather than as a smooth decline, which is precisely the architecture the University College London team is theorizing about.

Promising Theory, But the Proof Gap Is Real

The honest caveat here matters. The core two-stage claim rests on a review and theoretical synthesis, not a prospective cohort study tracking individuals from early-life injury through later disease onset. ^[4] The authors present a conceptual model and literature synthesis, which is a legitimate and valuable form of scientific contribution, but it is not the same as demonstrating the sequence in actual patients over decades. Aging and cancer research already treats the relationship between the two as bidirectional and multifactorial, with overlapping hallmarks including genomic instability, inflammation, and senescence operating simultaneously rather than in clean sequential stages. ^[9] The two-stage model may ultimately prove to be a useful organizing framework rather than a standalone causal discovery.

Scientists discover a two-stage aging process that may cause cancer and arthritis

A new theory suggests many age-related diseases may actually start decades before symptoms appear. Researchers say early-life damage — from infections, injuries, or genetic mutations — can remain…

— The Something Guy 🇿🇦 (@thesomethingguy) May 22, 2026

That said, dismissing the model for lacking final proof would be premature and intellectually lazy. Science advances by proposing falsifiable frameworks first and testing them second. The authors have done the harder intellectual work of identifying a coherent causal structure across multiple diseases and pointing toward specific mechanisms. The next step is longitudinal cohort studies stratifying early-life exposures against later disease endpoints, and animal intervention experiments testing whether repairing early damage reduces later cancer or arthritis incidence even when aging continues. ^[4] If those studies confirm the model, the implications for preventive medicine in middle age would be substantial.